Hemospermia following transrectal ultrasound-guided prostate biopsy: A prospective study

Murugesan Manoharan, R. Ayyathurai, A. M. Nieder, M. S. Soloway

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Hemospermia is known to be associated with transrectal ultrasound-guided prostate biopsy (TRUS-PB). The true incidence of hemospermia, its duration and implications are not well established. We performed a prospective observational study involving patients undergoing TRUS-PB for suspected prostate cancer at our institution. Sixty-three eligible men were included in the study. Most men (84%) undergoing TRUS-PB, who were able to ejaculate, experienced hemospermia, which was associated with some degree of anxiety. The mean duration of hemospermia was 3.5 (±1.7) weeks. The number of ejaculations before the complete resolution of hemospermia was 8 (±6.7). None of the clinical and pathological factors was a significant predictor of the duration of hemospermia. Patients should be adequately counseled before TRUS-PB to avoid undue anxiety and alterations in sexual activity.

Original languageEnglish
Pages (from-to)283-287
Number of pages5
JournalProstate Cancer and Prostatic Diseases
Volume10
Issue number3
DOIs
StatePublished - Sep 1 2007

Fingerprint

Hemospermia
Prostate
Prospective Studies
Biopsy
Anxiety
Ejaculation
Sexual Behavior
Observational Studies
Prostatic Neoplasms
Incidence

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Hemospermia following transrectal ultrasound-guided prostate biopsy : A prospective study. / Manoharan, Murugesan; Ayyathurai, R.; Nieder, A. M.; Soloway, M. S.

In: Prostate Cancer and Prostatic Diseases, Vol. 10, No. 3, 01.09.2007, p. 283-287.

Research output: Contribution to journalArticle

Manoharan, Murugesan ; Ayyathurai, R. ; Nieder, A. M. ; Soloway, M. S. / Hemospermia following transrectal ultrasound-guided prostate biopsy : A prospective study. In: Prostate Cancer and Prostatic Diseases. 2007 ; Vol. 10, No. 3. pp. 283-287.
@article{4845950c7ea641ae8aeaf376eadcaef6,
title = "Hemospermia following transrectal ultrasound-guided prostate biopsy: A prospective study",
abstract = "Hemospermia is known to be associated with transrectal ultrasound-guided prostate biopsy (TRUS-PB). The true incidence of hemospermia, its duration and implications are not well established. We performed a prospective observational study involving patients undergoing TRUS-PB for suspected prostate cancer at our institution. Sixty-three eligible men were included in the study. Most men (84{\%}) undergoing TRUS-PB, who were able to ejaculate, experienced hemospermia, which was associated with some degree of anxiety. The mean duration of hemospermia was 3.5 (±1.7) weeks. The number of ejaculations before the complete resolution of hemospermia was 8 (±6.7). None of the clinical and pathological factors was a significant predictor of the duration of hemospermia. Patients should be adequately counseled before TRUS-PB to avoid undue anxiety and alterations in sexual activity.",
author = "Murugesan Manoharan and R. Ayyathurai and Nieder, {A. M.} and Soloway, {M. S.}",
year = "2007",
month = "9",
day = "1",
doi = "10.1038/sj.pcan.4500955",
language = "English",
volume = "10",
pages = "283--287",
journal = "Prostate Cancer and Prostatic Diseases",
issn = "1365-7852",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Hemospermia following transrectal ultrasound-guided prostate biopsy

T2 - A prospective study

AU - Manoharan, Murugesan

AU - Ayyathurai, R.

AU - Nieder, A. M.

AU - Soloway, M. S.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Hemospermia is known to be associated with transrectal ultrasound-guided prostate biopsy (TRUS-PB). The true incidence of hemospermia, its duration and implications are not well established. We performed a prospective observational study involving patients undergoing TRUS-PB for suspected prostate cancer at our institution. Sixty-three eligible men were included in the study. Most men (84%) undergoing TRUS-PB, who were able to ejaculate, experienced hemospermia, which was associated with some degree of anxiety. The mean duration of hemospermia was 3.5 (±1.7) weeks. The number of ejaculations before the complete resolution of hemospermia was 8 (±6.7). None of the clinical and pathological factors was a significant predictor of the duration of hemospermia. Patients should be adequately counseled before TRUS-PB to avoid undue anxiety and alterations in sexual activity.

AB - Hemospermia is known to be associated with transrectal ultrasound-guided prostate biopsy (TRUS-PB). The true incidence of hemospermia, its duration and implications are not well established. We performed a prospective observational study involving patients undergoing TRUS-PB for suspected prostate cancer at our institution. Sixty-three eligible men were included in the study. Most men (84%) undergoing TRUS-PB, who were able to ejaculate, experienced hemospermia, which was associated with some degree of anxiety. The mean duration of hemospermia was 3.5 (±1.7) weeks. The number of ejaculations before the complete resolution of hemospermia was 8 (±6.7). None of the clinical and pathological factors was a significant predictor of the duration of hemospermia. Patients should be adequately counseled before TRUS-PB to avoid undue anxiety and alterations in sexual activity.

UR - http://www.scopus.com/inward/record.url?scp=34548449465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548449465&partnerID=8YFLogxK

U2 - 10.1038/sj.pcan.4500955

DO - 10.1038/sj.pcan.4500955

M3 - Article

C2 - 17310259

AN - SCOPUS:34548449465

VL - 10

SP - 283

EP - 287

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

SN - 1365-7852

IS - 3

ER -